A five-year grant, valued at $14.4 million, was made to Drexel University to be used to hire, retain, and support diverse early-career researchers.
Article from Philadelphia Business Journal
CHOP is teaming up with a San Diego company to develop “next-generation” biomanufacturing technologies.
Article from Philadelphia Business Journal
Focused on flexibility for associates, the official headquarters space, which employees will begin moving into the first half of 2022, will be designed specifically for in-person collaboration and company gatherings.
Exegenesis Bio of China’s business offices in Lower Gwynedd will give the company the flexibility to scale its office and laboratory space in the near term. It also plans to add 25 new clinical, regulatory, and administrative roles to the Philadelphia region within the next year.
The digital health joint venture formed by Comcast Corp. and Independence Blue Cross is set to launch its second product early next year.
Article from Philadelphia Business Journal
Amicus Therapeutics Inc., has unveiled plans to spinoff a “next-generation genetic medicine company” named Caritas Therapeutics.
Article from Philadelphia Business Journal
AmerisourceBergen Corp. has exited Chesterbrook and moved its new headquarters to Conshohocken.
Article from Philadelphia Business Journal
UPenn has made a $100 million commitment to establish the Center for Precision Engineering for Health said to bring together researchers to develop novel therapeutic biomaterials.
Article from Penn Today
Philadelphia’s startup scene is ranked amongst the best-performing in the world according to Startup Genome.
Article from Philadelphia Business Journal
The U.S. Food and Drug Administration has approved Opzelura™ cream for short-term and non-continuous chronic treatment of atopic dermatitis.
Article from Business Wire
